SHINE is excited to join other nuclear medicine leaders from around the world at EANM ’22 from Oct. 15-19 in Barcelona.

The 35th Annual Congress of the European Association of Nuclear Medicine will be a great place to catch up on all the latest in diagnostic imaging and therapeutics.

We’ll be in Booth #63 and would love to tell you about our plans to be the industry leader in fusion-driven medicine, including:

  • The world’s largest medical isotope production facility, which will initially focus on molybdenum-99 and is scheduled to get its operating license from the NRC next year.
  • Our current small-scale production of lutetium-177. We submitted a drug master file to the U.S. Food and Drug Administration earlier this year.
  • Our plan to be the only fully vertically integrated manufacturer of Lu-177.
  • How our fusion process will be safer and cleaner than fission-based methods while providing a stable U.S.-based supply source of critical isotopes.

Will we see you in Barcelona? Stop by our booth, or contact us here.

This field is for validation purposes and should be left unchanged.